Study aims to demonstrate the effectiveness and safety of empasiprubart compared to IVIg in improving functional ability, muscle strength and motor function in patients diagnosed with multifocal motor neuropathy.
At each visit participants will undergo muscle testing by the clinician for an objective guage of disease progression (include but not limited to- grip strength, and muscle testing) ; multiple quality of life questionnaires , blodo and urine collection, urine pregnancy test in WOCBP , 12 lead ECG and vital signs, study drug or placebo-IVIg administration
Subjects will be reimbursed for travel mileage to assist with on site study visits
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
Rebecca Traub
Neurology
Clinical or Medical
Interventional
Brain, Head, Nervous System
25-0771
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
